13F filing recap · Q3 2025
What did Jensen Investment Management buy in Q3 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$8.06B
Positions
87
Estimated turnover
23.9%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Jensen Investment Management opened new positions in Nordson, Fair Isaac, W.W. Grainger, Lululemon Athletica, and Landstar System, and exited Bio-Techne entirely. The firm substantially increased its stake in Eli Lilly and dramatically added to Veeva Systems and Meta Platforms. Notable trims included Stryker, Alphabet, Intuit, and KLA, while Zoetis, Amphenol, Accenture, Johnson & Johnson, and Home Depot were significantly reduced.